chills no fever; Really bad headache,; Diarrhea; dry heaves (one time during the day after injection); Persisting nausea; A couple rounds of coughing; Slight congestion; fatigue; Vomiting; Joint muscle aches; Abdominal pain; Discomfort; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP). The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Aug2021 (Lot number: FC3183) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Past drug history included: Bystolic 5mg nature. The following information was reported: CHILLS (non-serious) with onset 24Aug2021 17:30, outcome "recovered" (25Aug2021), described as "chills no fever"; HEADACHE (non-serious) with onset 24Aug2021 17:30, outcome "recovered" (25Aug2021), described as "Really bad headache,"; DIARRHOEA (non-serious) with onset 24Aug2021 17:30, outcome "recovered" (25Aug2021), described as "Diarrhea"; RETCHING (non-serious) with onset 24Aug2021 17:30, outcome "recovered" (25Aug2021), described as "dry heaves (one time during the day after injection)"; NAUSEA (non-serious) with onset 24Aug2021 17:30, outcome "not recovered", described as "Persisting nausea"; COUGH (non-serious) with onset 24Aug2021 17:30, outcome "recovered" (25Aug2021), described as "A couple rounds of coughing"; NASAL CONGESTION (non-serious) with onset 24Aug2021 17:30, outcome "recovered" (25Aug2021), described as "Slight congestion"; FATIGUE (non-serious) with onset 24Aug2021 17:30, outcome "recovered" (25Aug2021), described as "fatigue"; VOMITING (non-serious) with onset Aug2021, outcome "recovered" (Aug2021), described as "Vomiting"; MYALGIA (non-serious) with onset Aug2021, outcome "unknown", described as "Joint muscle aches"; DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "Discomfort"; ABDOMINAL PAIN (non-serious) with onset Aug2021, outcome "unknown", described as "Abdominal pain". Therapeutic measures were not taken as a result of chills, headache, diarrhoea, retching, nausea, cough, nasal congestion, fatigue.  Additional information: Time of vaccination was Approx. 5PM. Facility type vaccine was  Health Clinic. It was reported that the patient had really bad headache, chills no fever, diarrhea, dry heaves (one time during the day after injection), fatigue, joint muscle aches, persisting nausea (ongoing with both shots, still experiencing), a couple rounds of coughing, slight congestion and all occurred the first day after injection. Part way thru the second day, all were gone. It was reported that the patient had gastrointestinal symptoms. The patient had abdominal pain (more discomfort with both shots), vomiting (one day heave after 1st shots). Diarrhea was with 1st and 2nd shot, none with 2nd. Abdominal pain was more discomfort with both shots. Nausea: was ongoing with both shots,1 week after 2nd shots, still experiencing. Vomiting one day heave after 1st shots. 3x5 after 2nd one "wet". Event did not require the initiation of new medication or other treatment or procedure. The patient did not have a history of any previous allergies to specific products or any conditions indicative of an allergy. The patient was taking medications prior to the event being was Bystolic 5mg nature Throid. The patient was not seen in the Emergency Department and not hospatilized. Capillary refill time was > 3 sec. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient has been tested for COVID-19 or not Since the vaccination. The patient did not receive any recent vaccines for any other conditions prior to the event being. The patient did not receive any recent vaccines for SARS-CoV2 other than Pfizer-BioNTech COVID-19 Vaccine prior to the event being reported. The patient had not received any other vaccines around the time of Pfizer-BioNTech COVID-19 Vaccine vaccination. It was reported that the patient provided information to HCP regarding the reported adverse event(s) with the use of the product. The HCP considered the Pfizer product had a causal effect to the adverse event. It was known whether patient had Covid prior vaccination. Patient had no Covid tested post vaccination. The  patient did not require medical intervention. The  patient was not admitted to an Intensive Care Unit. Information on organ involvement was provided as no for Multiorgan involvement, Respiratory and Cardiovascular. Patient had no Bilateral wheeze/bronchospasm, Upper airway swelling, Tachypnoea, Increased use of accessory respiratory muscles, Recession, Cyanosis, Grunting, Dry cough, Hoarse voice, Difficulty breathing, Sensation of throat closure, Sneezing, Rhinorrhea, Measured hypotension,  Shock, Tachycardia, Loss of consciousness, Dermatological/Mucosal, Generalized urticaria, Generalized erythema, Angioedema, Generalized pruritus with skin rash, Generalized pruritus without skin rash, Generalized prickle sensation. Reduced central pulse volume and Decreased level of consciousness were unknown.   No follow-up attempts are possible. No further information is expected.